Antimicrobial Peptide
LL-37
The human cathelicidin antimicrobial peptide
Starting at $295
LL-37 is the only member of the cathelicidin family in humans — a natural antimicrobial peptide produced by immune cells, skin cells, and mucosal epithelia as the body's first line of defense. It has direct antibacterial, antifungal, antiviral, and immune-modulatory properties, with emerging applications in wound healing, skin conditions, and immune optimization.
Natural antimicrobial defense restored.
Antimicrobial Activity
Membrane Disruption
LL-37 disrupts bacterial and fungal cell membranes through amphipathic helix insertion — a mechanism resistant to the development of antibiotic resistance. Effective against antibiotic-resistant organisms.
Result: Broad-spectrum antimicrobial activity including drug-resistant organisms
Innate Immunity
Immune Activation
Acts as an alarmin — activating dendritic cells, mast cells, and macrophages to mount coordinated immune responses. Bridges innate and adaptive immunity.
Result: Enhanced innate immune response coordination
Tissue Repair
Wound Healing
Promotes wound healing through multiple mechanisms: chemotaxis of immune and repair cells, angiogenesis, and epithelial cell migration and proliferation.
Result: Accelerated wound closure and reduced infection risk
Clinical Benefits
What you can expect from LL-37 therapy
Antimicrobial activity
Direct activity against bacteria, fungi, and viruses — including antibiotic-resistant organisms like MRSA.
Wound healing
Accelerates wound closure through immune cell recruitment, angiogenesis, and epithelial repair.
Skin health
Deficiency in LL-37 is implicated in atopic dermatitis — topical supplementation supports skin barrier defense.
Antiviral protection
Demonstrated activity against multiple viruses including herpes simplex, influenza, and SARS-CoV-2.
Immune bridge
Connects innate and adaptive immunity, ensuring coordinated and comprehensive immune responses.
Neuroprotection
Emerging evidence for LL-37 in reducing neuroinflammation and supporting neuroprotective pathways.
The Process
What to expect & when
Realistic timeline for LL-37 results
Days 1–7
Acute Antimicrobial Effect
Direct antimicrobial activity begins. For wound healing applications, early improvement in infection control.
Weeks 1–3
Immune Activation
Enhanced innate immune response. Wound healing accelerates with improved cell recruitment.
Weeks 3–6
Tissue Repair
Structural wound healing and skin repair complete. Chronic conditions show progressive improvement.
Common questions
Everything you need to know about LL-37 therapy
Transparent Pricing
Consultation Fees
Physician-guided care with complete pricing clarity.
Generic Consultation
Includes Any & All Services
First Visit
$400
Follow-Up
$150
- Complete health assessment
- All service areas covered
- Personalized treatment plan
- Prescription if appropriate
Specialized Consultation
Skin, Hair, Wellness, Labs, Galleri
First Visit
$300
Follow-Up
$150
- Focused specialty review
- Lab analysis included
- Targeted treatment approach
- Follow-up protocol
Peptide Consultation
Weight loss & metabolic therapies
First Visit
$50
Follow-Up
$30
- Metabolic assessment
- GLP-1 or peptide evaluation
- Dosing strategy
- Prescription included